AR241117A2 - Procedimiento para la preparacion de complejos de flavanolignanos con fosfolipidos - Google Patents

Procedimiento para la preparacion de complejos de flavanolignanos con fosfolipidos

Info

Publication number
AR241117A2
AR241117A2 AR30453286A AR30453286A AR241117A2 AR 241117 A2 AR241117 A2 AR 241117A2 AR 30453286 A AR30453286 A AR 30453286A AR 30453286 A AR30453286 A AR 30453286A AR 241117 A2 AR241117 A2 AR 241117A2
Authority
AR
Argentina
Prior art keywords
complexes
flavanolignanes
phospholipids
preparation
formula
Prior art date
Application number
AR30453286A
Other languages
English (en)
Other versions
AR241117A1 (es
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11184188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR241117(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Application granted granted Critical
Publication of AR241117A1 publication Critical patent/AR241117A1/es
Publication of AR241117A2 publication Critical patent/AR241117A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE COMPLEJOS DE UNO O MAS FLAVANOLIGNANOS CON UNO O MAS FOSFOLIPIDOS, DE FORMULA (I) DONDE R Y R1, IGUALES O DIFERENTES ENTRE SI, REPRESENTAN EL RESTO ACILICO DE LOS ACIDOS PALMITICO, ESTEARICO, OLEICO, LINOLEICO O LINOLENICO; R+ REPRESENTA UNO DE LOS RESTOS -CH2-CH2-N+(CH3), -CH2-CH2-NH3, -CH2CH(COOH)-NH3; R3 REPRESENTA UNO DE LOS RESTOS (A), (B), Y (C). EL METODO CONSISTE EN HACER REACCIONAR UN FOSFOLIPIDO DE LA FORMULA (II) CON UN FLAVANO DE LA FORMULA (III) (DONDE R, R1, R2 Y R3 TIENEN LOS SIGNIFICADOS DESCRIPTOS ANTERIORMENTE), EN UNA RELACION MOLAR DE FLAVANOLIGNANO A FOSFOLIPIDO COMPRENDIDA ENTRE 1:0,3 Y 1:2 Y AISLAR LOS COMPLEJOS FORMADOS MEDIANTE PRECIPITACION CON NO DISOLVENTES, LIOFILIZACION O SECADO A VACIO.
AR304532A 1985-07-17 1986-07-17 Procedimiento para la preparacion de complejos de flavanolignanos con fosfolipidos AR241117A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8521602A IT1215291B (it) 1985-07-17 1985-07-17 Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.

Publications (2)

Publication Number Publication Date
AR241117A1 AR241117A1 (es) 1991-11-15
AR241117A2 true AR241117A2 (es) 1991-11-15

Family

ID=11184188

Family Applications (1)

Application Number Title Priority Date Filing Date
AR304532A AR241117A1 (es) 1985-07-17 1986-07-17 Procedimiento para la preparacion de complejos de flavanolignanos con fosfolipidos

Country Status (18)

Country Link
US (1) US4764508A (es)
EP (1) EP0209038B2 (es)
JP (1) JPH0692399B2 (es)
KR (1) KR890002430B1 (es)
AR (1) AR241117A1 (es)
AT (1) ATE46513T1 (es)
CA (1) CA1259324A (es)
CS (1) CS257289B2 (es)
DE (1) DE3665717D1 (es)
DK (1) DK170804B1 (es)
ES (1) ES2002101A6 (es)
FI (1) FI82940C (es)
GR (1) GR861825B (es)
HU (1) HU197332B (es)
IT (1) IT1215291B (es)
MX (1) MX3173A (es)
PT (1) PT82988B (es)
YU (1) YU45790B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
IT1222012B (it) * 1987-07-10 1990-08-31 Indena Spa Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono
ES2072416T3 (es) * 1990-07-05 1995-07-16 Indena Spa Complejos de derivados de neolignano con fosfolipidos, su uso y formulaciones farmaceuticas y cosmeticas que los contienen.
JP2672439B2 (ja) * 1991-09-25 1997-11-05 倉敷紡績 株式会社 強化押出成形体
GB9211659D0 (en) * 1992-06-02 1992-07-15 Indena Spa New alkaloid derivatives,their use and pharmaceutical formulations containing them
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
US5922757A (en) * 1996-09-30 1999-07-13 The Regents Of The University Of California Treatment and prevention of hepatic disorders
US6218437B1 (en) 1996-09-30 2001-04-17 The Regents Of The University Of California Treatment and prevention of hepatic disorders
ITMI20010429A1 (it) * 2001-03-02 2002-09-02 Indena Spa Composizioni farmaceutiche e cosmetiche per la protezione della pelledai danni indotti dalle radiazioni solari
KR100385366B1 (ko) * 2001-03-05 2003-05-27 부광약품 주식회사 생체이용율을 개선한 실리마린 제제 조성물
DE60220415T2 (de) 2001-07-27 2008-02-14 Neptune Technologies & Bioressources Inc., Laval Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
JP2005500349A (ja) * 2001-08-01 2005-01-06 アルタナ ファルマ アクチエンゲゼルシャフト 呼吸症候群のための選択的cox−2インヒビターと肺表面活性物質の組合せ物
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
ITMI20031388A1 (it) * 2003-07-08 2005-01-09 Indena Spa Formulazioni per il trattamento e la prevenzione di patologie della prostata.
ITMI20051942A1 (it) * 2005-10-14 2007-04-15 S I I T S R L Servizio Interna Composizioni galattogeniche a base di silimarina
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
EP1844785A1 (en) * 2006-04-13 2007-10-17 Indena S.P.A. Phospholipid complexes of olive fruits or leaves extracts having improved bioavailability
JP5349486B2 (ja) * 2007-11-15 2013-11-20 マダウス ゲーエムベーハー 肝炎の治療のためのシリビニン成分
CZ2008407A3 (cs) * 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
US8337835B2 (en) 2009-04-10 2012-12-25 Washington University Use of an endogenous ligand for peroxisome proliferator activated receptor alpha to treat liver disorders
IT1395351B1 (it) 2009-07-09 2012-09-14 Axioma Srl Formulazioni orali ad elevata biodisponibilita' orale costituite da miscele di frazioni lipofile e idrofile ottenute a partire dalla propoli
PT2493478T (pt) 2009-10-29 2018-04-03 Acasti Pharma Inc Composições terapêuticas concentradas de fosfolípidos
ITMI20121317A1 (it) 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
ITMI20121784A1 (it) 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
ITMI20130425A1 (it) * 2013-03-20 2014-09-21 Istituto Biochimico Italiano Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (nash)
CN103751785A (zh) * 2014-01-27 2014-04-30 江苏健佳药业有限公司 一种水飞蓟素磷脂复合物及其制备方法
CN104306332B (zh) * 2014-09-24 2017-02-15 东南大学 一种喜树碱类磷脂化合物、其药物组合物及应用
CN105983015B (zh) * 2015-03-23 2022-01-25 天士力医药集团股份有限公司 一种含有水飞蓟宾、ve的药物组合物
CN105983016B (zh) * 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
ITUB20155532A1 (it) * 2015-11-12 2017-05-12 St Biochimico Italiano Giovanni Lorenzini Spa Formulazione farmaceutica orale comprendente silibina
IT201600105201A1 (it) 2016-10-19 2018-04-19 Nutrilinea Srl Uso della fosfatidilserina per la prevenzione e il trattamento dei disturbi della prostata e relative composizioni farmaceutiche e nutraceutiche
WO2019070109A1 (es) * 2017-10-03 2019-04-11 Infinite Clinical Research International, S.A. De C.V. Triconjugado para el tratamiento de diabetes mellitus
AU2022277553A1 (en) 2021-05-18 2023-11-09 Prostasis, Llc Compositions comprising mixtures of compounds and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5060M (es) * 1965-12-22 1967-05-08
DE1767666C3 (de) * 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
JPS5958354U (ja) * 1982-10-13 1984-04-16 三菱重工業株式会社 伝熱板
SE442562B (sv) * 1983-01-26 1986-01-13 Asea Ab Sett att innesluta radioaktivt eller annat farligt avfall och en behallare for sadant avfall

Also Published As

Publication number Publication date
EP0209038B1 (en) 1989-09-20
AR241117A1 (es) 1991-11-15
MX3173A (es) 1993-09-01
PT82988A (en) 1986-08-01
DK170804B1 (da) 1996-01-22
DE3665717D1 (en) 1989-10-26
FI82940C (fi) 1991-05-10
DK339086D0 (da) 1986-07-16
DK339086A (da) 1987-01-18
ES2002101A6 (es) 1988-07-16
JPS6222781A (ja) 1987-01-30
KR870001188A (ko) 1987-03-12
YU128086A (en) 1988-02-29
KR890002430B1 (ko) 1989-07-03
FI862850A0 (fi) 1986-07-04
HUT44567A (en) 1988-03-28
JPH0692399B2 (ja) 1994-11-16
CS257289B2 (en) 1988-04-15
US4764508A (en) 1988-08-16
EP0209038B2 (en) 1996-03-27
HU197332B (en) 1989-03-28
FI82940B (fi) 1991-01-31
IT1215291B (it) 1990-01-31
CA1259324A (en) 1989-09-12
FI862850A (fi) 1987-01-18
ATE46513T1 (de) 1989-10-15
EP0209038A1 (en) 1987-01-21
IT8521602A0 (it) 1985-07-17
PT82988B (pt) 1988-07-01
GR861825B (en) 1986-11-18
YU45790B (sh) 1992-07-20

Similar Documents

Publication Publication Date Title
AR241117A2 (es) Procedimiento para la preparacion de complejos de flavanolignanos con fosfolipidos
IT1109331B (it) Procedimento per la preparazione di 9-(omega-eteroarilammino-alchilammino)-eritromicine e loro sali prodotto ottenuto e composizioni medicinali che li contengono
IT1062213B (it) Composti e composizioni di piridil guanidine particolarmente utili come ipotensivi e procedimento per la loro preparazione
ES2033985T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
ES2009723T3 (es) Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos.
BG28070A4 (en) Method of obtaining of phosphinovs acids
ES438179A1 (es) Un procedimiento para la preparacion de nuevos derivados de acido cefalosporanico.
IT1222412B (it) Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
DE69004403D1 (de) Orale Präparate.
IT7850986A0 (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonche'composizioni farmaceutiche che la contengono
IT8667976A0 (it) Derivati teofillinmetilditiolanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
IT8667809A0 (it) Derivati di 2 1 2 4 triazolin 5 one procedimento per la loro preparazione composizioni che li contengono e relativi impieghi
IT8148090A0 (it) Soluzioni concentrate stabili di cisplatina utili come composizioni farmaceutiche e relativo procedimento di produzione
IT8068555A0 (it) Derivati di 1 2 4 ossadiazolin 5 one procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
DK218388A (da) Aktivt princip isoleret fra hajvaev
IT1070223B (it) Composizione di fosforo luminescente e procedimento per la sua preparazione
IT1062383B (it) Composizioni di alogenuri di carbammoile..particolarmente utili per la preparazione di insetticidi
IT1121456B (it) 2 4 etil i pipera inil 4 fenilchinoline procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali composti
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
IT1048243B (it) 1..3 ditiol 2 ilidene malonati..particolarmente utili come fungici di..e procedimento per la loro preparazione
IT1047276B (it) Carbammati fosfonati..particolarmente utili come ignifuganti..e procedimento per la loro preparazione
BG34459A3 (en) Method of obtaining derivatives of 7 beta -amino- thiazolylacetamido-3-cephem-4-carbonic acid
GR1000098B (el) Παραγωγα διοξαζοκινης, παρασκευη των και συνθεσεις που τα περιεχουν.
BG34904A3 (en) Method for preparing d- sesquisodium salt of oxa- beta- lactam
ES2032209T3 (es) Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen.